Chronic
17
2
3
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
17.6%
3 terminated out of 17 trials
66.7%
-19.8% vs benchmark
6%
1 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (17)
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Association Between Conditioned Pain Modulation and the 4-week Response to Spinal Mobilization in Adults With Chronic Neck Pain
Wound Healing Endpoint and Recurrence
Gender Differences in Musculoskeletal Assessment Methods in Patients With Chronic Mechanical Low Back Pain
Pulsed Radiofrequency of Shoulder Individual Nerves Versus Brachial Plexus in Management of Chronic Post Mastectomy Shoulder Pain
Evaluation of the Safety and Clinical Performance of the Connected Catheter Study
Patient Registry for Patients With Chronic Subdural Hematoma
Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia
TKI Discontinuation in CML Patients of China
High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients.
Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy
Chronic Mountain Sickness, Systemic Vascular Function
Pulpectomy of Primary Molars With Rotary Instrumentation Versus Manual Instrumentation
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
Use of Busulfan as Conditioning Agent for a Second Stem Cell Transplant
Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living
Investigating the Role of the Premotor Cortex in Higher Cognitive Functions